Rigel Pharmaceuticals, Inc. Gains 90.97%
Tue, Jul 14, 2020 at 05:30 PM
Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ) rocketted at $4.13, a gain of 91%. On Mon 13 Jul 20, RIGL:NASDAQ touched a New 2-Week High of $2.16. The stock appeared on our News Catalysts scanner on Tue 14 Jul 20 at 02:13 PM in the 'MISCELLANEOUS' category. From Mon 29 Jun 20, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ)
Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
Top 10 Gainers:
- Perceptron, Inc. (PRCP:NASDAQ), 107.01%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 90.97%
- INmune Bio, Inc. (INMB:NASDAQ), 77.97%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 57.21%
- IMV Inc. (IMV:NASDAQ), 54.33%
- Dare Bioscience, Inc. (DARE:NASDAQ), 50.5%
- Vaxart, Inc. (VXRT:NASDAQ), 40.02%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 38.89%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 33.33%
- VIVUS, Inc. (VVUS:NASDAQ), 32.45%